Friday 6 November 2026 Export NEOG’s income statement to Excel — free account

Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue: +6.50%
EPS: −129.4%
Free cash flow: +135.6%
Total debt: −2.31%

Quarter to August 2026, against a year earlier

Insider buying

11.77 0.09 +0.77%

Follow NEOG

Alert me

Market cap: $2.6B
P/E: 0.0×
Fwd P/E: −93.3×
Dividend yield: —
F-score: 5/9
Altman Z: 1.11
Beneish M: −2.43
Dividend safety: n/a

Overview

Neogen Corporation (NEOG) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Neogen Corporation (NEOG) trades at a P/S ratio of 2.9×. Over the past ten years it has ranged from 1.1× (April 2025) to 12.4× (September 2018); the current reading is higher than 15% of that period. That is above the Medical Devices industry median of 2.5× and below the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/NEOG/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Neogen Corporation P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/NEOG/metrics/ps-ratio">Neogen Corporation (NEOG) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2026	2.2×	61.59%
FY2025	1.4×	(55.22%)
FY2024	3.1×	(23.31%)
FY2023	4.0×	(25.69%)
FY2022	5.4×	(47.88%)
FY2021	10.4×	14.88%
FY2020	9.0×	27.86%
FY2019	7.1×	(27.75%)
FY2018	9.8×	45.96%
FY2017	6.7×	16.45%

Period	P/S ratio	Change
Aug 2026	2.9×	27.95%
May 2026	2.2×	(20.06%)
Feb 2026	2.8×	90.72%
Nov 2025	1.5×	5.84%
43 more quarters	Free account

Against its own ten years

Low 1.1× High 12.4×

Ten-year median 6.7×

Current reading's percentile 16

Company	P/S ratio
INSP Inspire Medical Systems, Inc. compare	2.2×
ITGR Integer Holdings Corporation compare	2.4×
NEOG Neogen Corporation	2.9×
TMDX TransMedics Group, Inc. compare	3.3×
UFPT UFP Technologies, Inc. compare	3.6×
ESTA Establishment Labs Holdings Inc. compare	7.9×
AXGN AxoGen, Inc. compare	10.1×
BFLY Butterfly Network, Inc. compare	13.1×
ALMR Alamar Biosciences, Inc. compare	17.8×
Medical Devices industry median	2.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Neogen Corporation (NEOG) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on NEOG

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on NEOG

Stockrow Weekly